Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.
Verona Pharma has blockbuster hopes for its recently ... regulator worldwide to approve Sanofi and Regeneron's big-selling IL-4 and IL-13 inhibitor Dupixent (dupilumab) as a treatment for the ...
Verona Pharma has claimed FDA approval for its ... verdict on a COPD indication for Sanofi and Regeneron’s big-selling IL-4 and IL-13 inhibitor Dupixent (dupilumab) in September, after a three ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback